1019 related articles for article (PubMed ID: 17697901)
1. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
[TBL] [Abstract][Full Text] [Related]
2. A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
Antonijoan RM; García-Gea C; Puntes M; Valle M; Esbri R; Fortea J; Barbanoj MJ
Clin Drug Investig; 2007; 27(7):453-61. PubMed ID: 17563125
[TBL] [Abstract][Full Text] [Related]
3. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet [20 mg] versus desloratadine capsule [5 mg]: a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
Devillier P
Clin Ther; 2007 Dec; 29(12):2774-5, author reply 2775-6. PubMed ID: 18201596
[No Abstract] [Full Text] [Related]
4. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
Gispert J; Antonijoan R; Barbanoj M; Gich I; Garcia E; Esbrí R; Luria X
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers.
Antonijoan R; Coimbra J; García-Gea C; Puntes M; Gich I; Campo C; Valiente R; Labeaga L
Curr Med Res Opin; 2017 Jan; 33(1):129-136. PubMed ID: 27659218
[TBL] [Abstract][Full Text] [Related]
6. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers.
Frossard N; Benabdesselam O; Purohit A; Mounedji N; Pauli G
Fundam Clin Pharmacol; 2000; 14(4):409-13. PubMed ID: 11030449
[TBL] [Abstract][Full Text] [Related]
7. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
Sastre J
Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin.
Denham KJ; Boutsiouki P; Clough GF; Church MK
Inflamm Res; 2003 Oct; 52(10):424-7. PubMed ID: 14520518
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
Carey W; Warrington S; Boyce M; Luria X
Drugs Exp Clin Res; 2002; 28(6):243-7. PubMed ID: 12776578
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
11. A study comparing the inhibitory effects of single and repeated oral doses of ebastine and fexofenadine against histamine-induced skin reactivity.
Barbanoj MJ; Antonijoan RM; García-Gea C; Morte A; Gich I; Gispert J; Garcia E; Esbrí R; Luria X
Int Arch Allergy Immunol; 2003 Nov; 132(3):263-7. PubMed ID: 14646388
[TBL] [Abstract][Full Text] [Related]
12. Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours.
Purohit A; Melac M; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2004 Jun; 92(6):635-40. PubMed ID: 15237765
[TBL] [Abstract][Full Text] [Related]
13. Duration of the antihistaminic effect after discontinuation of ebastine.
Frossard N; Vital-Durand D; Mounedji N; Valleteau A
Allergy; 2001 Jun; 56(6):553-7. PubMed ID: 11421903
[TBL] [Abstract][Full Text] [Related]
14. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
Meltzer EO; Gillman SA
Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
Crampton HJ
Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects.
Grant JA; Danielson L; Rihoux JP; DeVos C
Allergy; 1999 Jul; 54(7):700-7. PubMed ID: 10442525
[TBL] [Abstract][Full Text] [Related]
18. Consistency of the efficacy of cetirizine and ebastine on skin reactivity.
Frossard N; Melac M; Benabdesselam O; Pauli G
Ann Allergy Asthma Immunol; 1998 Jan; 80(1):61-5. PubMed ID: 9475569
[TBL] [Abstract][Full Text] [Related]
19. Randomized, single-blind, crossover comparison of two rupatadine tablet formulations on histamine-induced cutaneous response in healthy adult volunteers.
Usharani P; Naidu MU; Reddy BS; Reddy M
Curr Ther Res Clin Exp; 2007 Nov; 68(6):400-8. PubMed ID: 24692771
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
